{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T22:06:06Z","timestamp":1789596366053,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP20fk0108094"],"award-info":[{"award-number":["JP20fk0108094"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jiac-j.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Infection and Chemotherapy"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/j.jiac.2021.06.017","type":"journal-article","created":{"date-parts":[[2021,6,30]],"date-time":"2021-06-30T08:17:34Z","timestamp":1625041054000},"page":"1562-1570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Comparison of mortality between echinocandins and polyenes for an initial treatment of candidemia: A systematic review and meta-analysis"],"prefix":"10.1016","volume":"27","author":[{"given":"Hideo","family":"Kato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mao","family":"Hagihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuichi","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuhiro","family":"Asai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuka","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takuya","family":"Iwamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshige","family":"Mikamo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jiac.2021.06.017_bib1","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1056\/NEJMra1315399","article-title":"Invasive candidiasis","volume":"373","author":"Kullberg","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2021.06.017_bib2","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1016\/j.diagmicrobio.2012.10.003","article-title":"Epidemiology and outcomes of candidemia in 3648 patients: data from the prospective antifungal therapy (PATH Allliance) registry, 2004-2008","volume":"74","author":"Pfaller","year":"2012","journal-title":"Diagn Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.017_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1378\/chest.118.1.146","article-title":"The influence of inadequate antimicrobial treatment of bloodstream infections on patient outcomes in the ICU setting","volume":"118","author":"Ibrahim","year":"2000","journal-title":"Chest"},{"key":"10.1016\/j.jiac.2021.06.017_bib4","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1086\/317451","article-title":"A randomized, double-blind comparative trial evaluating the safety of liposomal amphotericin B versus amphotericin B lipid complex in the empirical treatment of febrile neutropenia. L Amph\/ABLC Collaborative Study Group","volume":"31","author":"Wingard","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.017_bib5","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1016\/S1473-3099(03)00831-4","article-title":"Management of Candida species infections in critically ill patients","volume":"3","author":"Eggimann","year":"2003","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.017_bib6","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/1469-0691.12039","article-title":"ESCMID guideline for the diagnosis and management of Candida diseases 2012: non-neutropenia adult patients","volume":"18","author":"Cornely","year":"2012","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/j.jiac.2021.06.017_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/cid\/civ933","article-title":"Clinical practice guideline for the management of candidiasis: 2016 update by the Infectious Diseases Society of America","volume":"62","author":"Pappas","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.017_bib8","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1080\/1120009X.2020.1783154","article-title":"Species distribution and antifungal susceptibilities of blood stream Candida isolates: a nine-years single center survey","volume":"32","author":"Brescini","year":"2020","journal-title":"J Chemother"},{"key":"10.1016\/j.jiac.2021.06.017_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.1001692","article-title":"Fitness trade-offs restrict the evolution of resistance to amphotericin B","volume":"11","author":"Vincent","year":"2013","journal-title":"PLoS Biol"},{"key":"10.1016\/j.jiac.2021.06.017_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3390\/jof7060405","article-title":"Resistance to echinocandins complicates a case of Candida albicans bloodstream infection: a case report","volume":"7","author":"Trovato","year":"2021","journal-title":"J Fungi (Basel)"},{"key":"10.1016\/j.jiac.2021.06.017_bib11","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1080\/14737167.2016.1202766","article-title":"Cost-effectiveness of caspofungin versus liposomal amphotericin B in the treatment of systemic fungal infections: a systematic review of economic analyses","volume":"16","author":"Mistro","year":"2016","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/j.jiac.2021.06.017_bib12","doi-asserted-by":"crossref","first-page":"b2535","DOI":"10.1136\/bmj.b2535","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"339","author":"Moher","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.jiac.2021.06.017_bib13","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/j.jiac.2021.06.017_bib14","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1056\/NEJMoa040446","article-title":"Caspofungin versus liposomal amphotericin B for empirical antifungal therapy in patients with persistent fever and neutropenia","volume":"351","author":"Walsh","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2021.06.017_bib15","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1128\/JCM.00179-11","article-title":"Diagnostic issues, clinical characteristics, and outcomes for patients with fungemia","volume":"49","author":"Arendrup","year":"2011","journal-title":"J Clin Microbiol"},{"key":"10.1016\/j.jiac.2021.06.017_bib16","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1016\/j.ijantimicag.2012.07.022","article-title":"Clinical characteristics of candidaemia in adults with haematological malignancy, and antimicrobial susceptibilities of the isolates at a medical centre in Taiwan, 2001-2010","volume":"40","author":"Chen","year":"2012","journal-title":"Int J Antimicrob Agents"},{"key":"10.1016\/j.jiac.2021.06.017_bib17","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00134-014-3400-y","article-title":"Prognostic factors and historical trends in the epidemiology of candidemia in critically ill patients: an analysis of five multicenter studies sequentially conducted over a 9-yea period","volume":"40","author":"Colombo","year":"2014","journal-title":"Intensive Care Med"},{"key":"10.1016\/j.jiac.2021.06.017_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.2147\/TCRM.S68450","article-title":"Bloodstream infections in patients with hematological malignancies: which is more fatal \u2013 cancer or resistant pahogens?","volume":"10","author":"Gedik","year":"2014","journal-title":"Therapeut Clin Risk Manag"},{"key":"10.1016\/j.jiac.2021.06.017_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.jhin.2014.02.006","article-title":"Nosocomial Candida parapsilosis candidaemia: risk factors, antifungal susceptibility and outcome","volume":"87","author":"Hirai","year":"2014","journal-title":"J Hosp Infect"},{"key":"10.1016\/j.jiac.2021.06.017_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0127534","article-title":"Clinical and therapeutic aspects of candidemia: a five year single centre study","volume":"10","author":"Bassetti","year":"2015","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2021.06.017_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1080\/14787210.2016.1197118","article-title":"Management of candidemia in patients with Clostridium difficile infection","volume":"14","author":"Falcone","year":"2016","journal-title":"Expert Rev Anti Imfect Ther"},{"key":"10.1016\/j.jiac.2021.06.017_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s10096-015-2527-2","article-title":"Initial antifungal strategy does not correlate with mortality in patients with candidemia","volume":"35","author":"Murri","year":"2016","journal-title":"Eur J Clin Microbiol Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.017_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0176576","article-title":"Candidemia in the elderly: what does it change?","volume":"12","author":"Barchiesi","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2021.06.017_bib24","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s15010-017-1050-z","article-title":"Risk factors and predictors of mortality of candidaemia among critically ill patients: role of antifungal prophylaxis in its development and in selection of non-albicans species","volume":"45","author":"Papadimitriou-Olivgeris","year":"2017","journal-title":"Infection"},{"key":"10.1016\/j.jiac.2021.06.017_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185339","article-title":"Candidemia in non-ICU surgical wards: comparison with medical wards","volume":"12","author":"Vena","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2021.06.017_bib26","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.7754\/Clin.Lab.2019.190110","article-title":"Impact on antifungal susceptibility patterns of previous vs. revised Clinical and Laboratory Standards Institute breakpoints for Candida species isolated from candidemia: experience of two tertiary care institutions in Japan","volume":"65","author":"Hirano","year":"2019","journal-title":"Clin Lab"},{"key":"10.1016\/j.jiac.2021.06.017_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222356","article-title":"Risk factors and outcomes of patients with ocular involvement of candidemia","volume":"14","author":"Son","year":"2019","journal-title":"PloS One"},{"key":"10.1016\/j.jiac.2021.06.017_bib28","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s40560-020-00450-7","article-title":"Impact of host- and early treatment-related factors on mortality in ICU patients with candidemia: a bicentric retrospective observational study","volume":"8","author":"Ohki","year":"2020","journal-title":"J Intensive Care"},{"key":"10.1016\/j.jiac.2021.06.017_bib29","first-page":"261164","article-title":"Echinocandins versus non-echinocandins for the treatment of invasive candidiasis: a meta-analysis of randomized controlled trials","author":"Tashiro","year":"2020","journal-title":"J Infect Chemother"},{"key":"10.1016\/j.jiac.2021.06.017_bib30","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1128\/AAC.00955-08","article-title":"Activity of anidulafungin in a murine model of Candida krusei infection: evaluation of mortality and disease burden by quantitative tissue cultures and measurement of serum (1, 3)-beta-D-glucan levels","volume":"53","author":"Ostrosky-Zeichner","year":"2009","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2021.06.017_bib31","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1128\/AAC.00783-20","article-title":"Genetic basis of azole and echinocandin resistance in clinical Candida glabrata in Japan","volume":"64","author":"Khalifa","year":"2020","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.jiac.2021.06.017_bib32","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1097\/MD.0b013e3181e9441b","article-title":"Drug-induced nephrotoxicity caused by amphotericin B lipid complex and liposomal amphotericin B: a review and meta-analysis","volume":"89","author":"Safdar","year":"2010","journal-title":"Medicine"},{"key":"10.1016\/j.jiac.2021.06.017_bib33","first-page":"CD000969","article-title":"Amphotericin B lipid soluble formulations versus amphotericin B in cancer patients with neutropenia","volume":"2014","author":"Johansen","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.jiac.2021.06.017_bib34","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(07)60605-9","article-title":"Micafungin versus liposomal amphotericin B for candidaemia and invasive candidosis: a phase III randomized double-blind trial","volume":"369","author":"Kuse","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/j.jiac.2021.06.017_bib35","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1056\/NEJMoa021585","article-title":"Comparison of caspofungin and amphotericin B for invasive candidiasis","volume":"347","author":"Mora-Duarte","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/j.jiac.2021.06.017_bib36","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1093\/cid\/ciu158","article-title":"Initial use of echinocandins does not negatively influence outcome in Candida parapsilosis bloodstream infection: a propensity score analysis","volume":"58","author":"Fernandez-Ruiz","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.jiac.2021.06.017_bib37","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1592\/phco.30.12.1207","article-title":"Comparative efficacy of echinocandins and nonechinocandins for the treatment of Candida parapsilosis infections: a meta-analysis","volume":"30","author":"Kale-Pradhan","year":"2010","journal-title":"Pharmacotherapy"},{"key":"10.1016\/j.jiac.2021.06.017_bib38","first-page":"116","volume":"9","author":"Kumar","year":"2018","journal-title":"Mydology"},{"key":"10.1016\/j.jiac.2021.06.017_bib39","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.4065\/83.9.1011","article-title":"Treatment of invasive candida infections: systematic review and meta-analysis","volume":"83","author":"Gafter-Gvili","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/j.jiac.2021.06.017_bib40","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1378\/chest.09-0087","article-title":"Initiation of inappropriate antimicrobial therapy results in a fivefold reduction of survival in human septic shock","volume":"136","author":"Kumar","year":"2009","journal-title":"Chest"}],"container-title":["Journal of Infection and Chemotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1341321X21001781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T19:02:10Z","timestamp":1761159730000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1341321X21001781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,11]]},"references-count":40,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S1341321X21001781"],"URL":"https:\/\/doi.org\/10.1016\/j.jiac.2021.06.017","relation":{},"ISSN":["1341-321X"],"issn-type":[{"value":"1341-321X","type":"print"}],"subject":[],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of mortality between echinocandins and polyenes for an initial treatment of candidemia: A systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"Journal of Infection and Chemotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jiac.2021.06.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Japanese Society of Chemotherapy and The Japanese Association for Infectious Diseases. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}